Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 22, 2025. (Total: 235574Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Neuroendocrine Tumors and MTOR[original query]
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Science (New York, N.Y.) 2011 1 331 (6021): 1199-203.
Jiao Yuchen, Shi Chanjuan, Edil Barish H, de Wilde Roeland F, Klimstra David S, Maitra Anirban, Schulick Richard D, Tang Laura H, Wolfgang Christopher L, Choti Michael A, Velculescu Victor E, Diaz Luis A, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickol
The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Cancer research 2012 Nov 72 (22): 5683-91.
Serra Stefano, Zheng Lei, Hassan Manal, Phan Alexandria T, Woodhouse Linda J, Yao James C, Ezzat Shereen, Asa Sylvia
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
International journal of biological sciences 2016 12 (12): 1523-1532.
Chou Wen-Chi, Lin Po-Han, Yeh Yi-Chen, Shyr Yi-Ming, Fang Wen-Liang, Wang Shin-E, Liu Chun-Yu, Chang Peter Mu-Hsin, Chen Ming-Han, Hung Yi-Ping, Li Chung-Pin, Chao Yee, Chen Ming-Hua
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Oncotarget 2017 Nov 8 (55): 93464-93475.
Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael
The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors.
Journal of gastrointestinal oncology 2019 8 10 (4): 645-651.
Nuñez Jose Eduardo, Donadio Mauro, Filho Duilio Rocha, Rego Juliana Florinda, Barros Milton, Formiga Maria Nirvana, Lopez Rossana, Riechelmann Rach
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019 3 25 (6): 580-588.
Tirosh Amit, Killian J Keith, Zhu Yuelin Jack, Petersen David, Walling Jennifer, Mor-Cohen Ronit, Neychev Vladimir, Stevenson Holly, Keutgen Xavier M, Patel Dhaval, Nilubol Naris, Meltzer Paul, Kebebew Electr
Comparative targeted genome profiling between solid and liquid biopsies in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a proof-of-concept pilot study.
Neuroendocrinology 2024 10 1-20.
Irene Gagliardi, Federica Campolo, Patricia Borges de Souza, Lucrezia Rossi, Manuela Albertelli, Federica Grillo, Luigi Caputi, Massimiliano Mazza, Antongiulio Faggiano, Maria Chiara Zatel
TOP